From the patient’s own tissue
Bone marrow and adipose-derived options may be discussed when clinically appropriate.
Advanced biologic support
Stem cell therapies are considered when the repair conversation needs a deeper biologic signal.
Stem cell therapies are part of the biologics category at Idaho Regenerative Medicine (IRM) and may be considered in select orthopedic, tissue repair, or regenerative contexts.
How IRM thinks
Where stem cell therapies may fit.
Stem cell therapies may include autologous sources such as bone marrow or adipose tissue, as well as carefully selected donor-derived options such as umbilical cord-derived products when appropriate.
In regenerative orthopedics, stem cell therapies are not viewed as a shortcut. They are considered within the same clinical logic: stabilize the joint, improve the repair environment, and support the tissue's ability to respond.
The decision to use a stem cell therapy depends on the tissue involved, the chronicity of the injury, the level of degeneration or instability, the patient's health terrain, and the goals of care.
Clinical context
A focused therapy inside a bigger plan.
This therapy is selected within a bigger orthopedic and whole-person plan. The best starting point is understanding the tissue target, the repair environment, and the sequence of care.
Selected biologic options
Donor-derived products may be considered in specific cases based on the treatment plan and clinical context.
Repair environment support
Stem cell therapies may be used as part of a larger regenerative orthopedic strategy.
What to expect
For patients considering stem cell therapies.
Every plan is individualized. This overview helps you understand the conversation — not predict your specific procedure or outcome.
Assessment comes first
Stem cell therapies are not a first-line shortcut. The consult and appropriate orthopedic assessment help clarify tissue targets, stability needs, and whether the internal repair environment is ready.
Procedure context
Depending on the plan, preparation may involve bone marrow or adipose collection, or use of selected donor-derived products. Injections are typically ultrasound-guided when targeting specific structures.
Recovery & activity
Activity restrictions, rehabilitation, and follow-up timing vary by tissue, procedure type, and individual response. Your provider gives specific guidance — not generic post-op rules.
Hope without hype
Outcomes depend on age, tissue quality, chronicity, inflammation, sleep, metabolism, and adherence to the plan. IRM discusses risks, alternatives, and reasonable expectations before proceeding.
Are stem cell therapies a stand-alone fix?
IRM does not frame them as a magic fix. They work best when selected within the right assessment, stability plan, and internal repair environment.
Are stem cell therapies the same as PRP?
No. PRP is platelet-rich plasma from blood. Stem cell therapies are a different biologic category with different considerations.
How do I know if this belongs in my plan?
The starting point is the Get to Know You Consult. If IRM may be a fit, the next step may include assessment, orthopedic exam, ultrasound imaging when appropriate, and a personalized care discussion.
What is the difference between bone marrow and umbilical options?
Autologous options use your own tissue; donor-derived products may be considered in specific clinical contexts. Each has different preparation, considerations, and candidacy — discussed individually.
How much downtime should I expect?
Downtime varies by procedure type and injection site. Your provider gives specific activity guidance rather than one-size-fits-all restrictions.
Begin
The next step is a conversation,
not a commitment.
Start with a focused conversation to share what has been happening, name what you are hoping for, and understand whether IRM may be the right place for your next step.